Abstract:RATIONALE: Osteoporosis is common in individuals with chronic obstructive pulmonary disease. Lung-specific factors, including radiographic emphysema, independently associate with low bone mineral density in cross-sectional smoking cohorts. However, factors associated with progressive bone loss in smokers are understudied and largely unknown.OBJECTIVES: To determine the relationship between radiographic emphysema, circulating bone metabolism markers, and pulmonary function and accelerated bone mineral density loss in smokers.METHODS: Two hundred and forty male and female current and former smokers, 40 years of age or older, underwent baseline and 2-year assessments of pulmonary function, computed tomography-assessed emphysema, dual X-ray absorptiometry-measured bone mineral density, and circulating bone metabolism biomarker levels (type I collagen C-telopeptide [CTX], amino-terminal propeptide of type I procollagen [P1NP]). The association of radiographic emphysema, bone metabolism biomarker levels, and pulmonary function with accelerated hip bone mineral density loss, defined by the 75th percentile of annual hip bone mineral density decline, was determined by logistic regression modeling with adjustment for age, sex, inhaled and intermittent steroid use, active smoking, body mass index, and the presence of baseline low hip bone mineral density.RESULTS: Of those participants with accelerated hip bone mineral density loss, 22% had moderate or severe visually assessed emphysema compared with 7.2% of smokers without accelerated bone mineral density decline. Moderate to severe visually assessed emphysema (odds ratio, 2.84; 95% confidence interval, 1.01-7.98 compared with trace/mild or no visually assessed emphysema) and the 75th percentile of CTX levels (odds ratio, 2.38; 95% confidence interval, 1.20-4.72 compared with CTX levels below the 75th percentile), a marker of bone resorption, were associated with accelerated hip bone mineral density decline after adjustment for covariates and the presence of baseline low hip bone mineral density. FEV<sub>1</sub>% predicted was not associated with accelerated bone mineral density decline after adjustment for covariates. Multivariate modeling showed moderate to severe visually assessed emphysema, and the 75th percentiles of CTX were independently associated with accelerated hip bone mineral density decline after adjustment for covariates.CONCLUSIONS: Emphysema and elevated markers of bone resorption are independently associated with progressive bone mineral density loss in smokers. These clinical markers may guide targeted bone mineral density screening and monitoring in smokers at highest risk.

Tobacco toxins induce osteoporosis through ferroptosis

Tobacco toxins trigger bone marrow mesenchymal stem cells aging by inhibiting mitophagy

Exploring the relationship between pyroptosis and inflammatory bone loss: Evidence from a cigarette smoke-induced osteoporosis mouse model

Cigarette smoke-associated inflammation impairs bone remodeling through NFκB activation

Bone Turnover in Passive Smoking Female Rat: Relationships to Change in Bone Mineral Density

Sirt3-MnSOD Axis Represses Nicotine-Induced Mitochondrial Oxidative Stress and Mtdna Damage in Osteoblasts.

Exposure to Tobacco Smoke Increases Bone Loss in Spontaneously Hypertensive Rats

Smoking and osteoimmunology: Understanding the interplay between bone metabolism and immune homeostasis

Cigarette smoke inhibits osteogenic differentiation and proliferation of human osteoprogenitor cells in monolayer and three-dimensional collagen gel culture

Effect of curcumin on lung epithelial injury and ferroptosis induced by cigarette smoke

Consensus Gene Modules Related to Levels of Bone Mineral Density (BMD) among Smokers and Nonsmokers

Cigarette Smoke Extract Inhibits Chemotaxis and Collagen Gel Contraction Mediated by Human Bone Marrow Osteoprogenitor Cells and Osteoblast-Like Cells

Ferroptosis‐associated cholesterol metabolism regulated by p85α in human bronchial epithelial cells with smoking

Iron overload‐induced ferroptosis of osteoblasts inhibits osteogenesis and promotes osteoporosis: an in vitro and in vivo study

Maqui Berry and Ginseng Extracts Reduce Cigarette Smoke-Induced Cell Injury in a 3D Bone Co-Culture Model

Effects of Nicotine on the Metabolism and Gene Expression Profile of Sprague‑Dawley Rat Primary Osteoblasts.

Smoking‐Induced Risk of Osteoporosis Is Partly Mediated by Cadmium From Tobacco Smoke: The MrOS Sweden Study

Effect of Epimedium Pubescen Flavonoid on Bone Mineral Status and Bone Turnover in Male Rats Chronically Exposed to Cigarette Smoke

[EXPERIMENTAL STUDY ON EFFECT OF NICOTINE INTAKE ON IMPACT OF BONE MICROSTRUCTURE AND OXIDATIVE STRESS IN RATS].

Effect of Epimedium Pubescen Flavonoid on Bone Mineral Density and Biomechanical Properties of Femoral Distal End and Femoral Diaphysis of Passively Smoking Male Rats

Radiographic Emphysema, Circulating Bone Biomarkers, and Progressive Bone Mineral Density Loss in Smokers